⚠ Disclaimer: This report is generated using AI tools and is for informational purposes only. It does not constitute investment advice. Please consult a registered financial advisor before making any investment decisions.

ROUTE - Fundamental Analysis: Financial Health & Valuation

Back to List

Rating: 3.4

Last Updated Time : 17 Jan 26, 02:44 pm

Fundamental Rating: 3.4

Stock Code ROUTE Market Cap 4,047 Cr. Current Price 642 ₹ High / Low 1,328 ₹
Stock P/E 29.1 Book Value 205 ₹ Dividend Yield 1.71 % ROCE 16.3 %
ROE 12.4 % Face Value 10.0 ₹ DMA 50 700 ₹ DMA 200 864 ₹
Chg in FII Hold -0.62 % Chg in DII Hold -0.67 % PAT Qtr 32.9 Cr. PAT Prev Qtr 30.4 Cr.
RSI 34.2 MACD -11.8 Volume 1,34,480 Avg Vol 1Wk 1,21,057
Low price 636 ₹ High price 1,328 ₹ PEG Ratio 0.42 Debt to equity 0.00
52w Index 0.79 % Qtr Profit Var -31.4 % EPS 18.8 ₹ Industry PE 13.8

📊 Financials: Route Mobile shows moderate profitability with EPS at 18.8 ₹. ROE of 12.4% and ROCE of 16.3% reflect decent efficiency in capital utilization. Debt-to-equity is 0.00, highlighting a debt-free balance sheet. Quarterly PAT improved to 32.9 Cr. from 30.4 Cr., but profit variation (-31.4%) indicates earnings inconsistency. Dividend yield of 1.71% adds moderate investor appeal.

💹 Valuation: Current P/E of 29.1 is higher than the industry average of 13.8, suggesting premium valuation. Book Value of 205 ₹ gives a P/B ratio of ~3.13, which is moderately expensive. PEG ratio of 0.42 indicates earnings growth is somewhat aligned with valuation, but volatility remains a concern. Intrinsic value appears lower than current market price, making the stock slightly stretched.

🏢 Business Model & Health: Route Mobile operates in cloud communication and messaging solutions, serving enterprises with SMS, voice, and digital communication services. Competitive advantage lies in global presence, diversified client base, and technology-driven offerings. Overall health is strong with debt-free status and consistent profitability, though earnings volatility and premium valuations limit attractiveness.

🎯 Entry Zone: Current price of 642 ₹ is near its 52-week low (636 ₹), far below its high (1,328 ₹). RSI at 34.2 suggests oversold conditions, indicating potential for a rebound. A safer entry zone would be around 600–620 ₹, offering better risk-reward balance.

📈 Long-Term Holding Guidance: Route Mobile is suitable for long-term holding given its strong business model and debt-free balance sheet. Investors should accumulate on dips, with patience for earnings stability and valuation alignment.


Positive

  • 📈 Debt-free balance sheet (Debt-to-equity 0.00).
  • 💹 Healthy ROE (12.4%) and ROCE (16.3%).
  • 🏢 Strong business model in cloud communication services.
  • 💸 Dividend yield of 1.71% adds investor appeal.

Limitation

  • ⚠️ High P/E ratio (29.1) vs industry average (13.8).
  • 📉 Expensive P/B ratio (~3.13).
  • 📊 Quarterly profit variation (-31.4%) shows inconsistency.

Company Negative News

  • 📉 Decline in FII holdings (-0.62%).
  • ⚠️ Reduction in DII holdings (-0.67%).

Company Positive News

  • 📈 PAT growth compared to previous quarter (32.9 Cr. vs 30.4 Cr.).
  • 💹 Debt-free status with consistent dividend payouts.

Industry

  • 🌐 Cloud communication and messaging sector supported by enterprise digital adoption.
  • 📊 Industry PE at 13.8, highlighting Route Mobile’s premium valuation multiples.

Conclusion

⚖️ Route Mobile is a fundamentally strong, debt-free company with a solid business model in cloud communications. However, current valuations are stretched, and earnings volatility persists. Entry is advisable only around 600–620 ₹. Long-term investors can hold cautiously, with confidence in its technology-driven growth but patience for improved earnings consistency.

Would you like me to also prepare a peer comparison with Tanla Platforms and other communication-tech firms to highlight Route Mobile’s relative valuation and growth prospects?

NIFTY 50 - Fundamental Stock Watchlist

NEXT 50 - Fundamental Stock Watchlist

MIDCAP - Fundamental Stock Watchlist

SMALLCAP - Fundamental Stock Watchlist